Business

Elbow Lesion Market Analysis and In-depth Research Growth and Forecast 2018-2026

The elbow lesion market is classified on the basis of treatment methods into surgical and non-surgical therapies. Arthroscopic surgery and open surgery are types of surgical therapies performed. Non-surgical therapies comprise drugs and physical therapy.

Various non-steroidal anti-inflammatory drugs (NSAIDS) such as ibuprofen, aspirin, and cortisone are administered to control pain. Other drugs used for treatment of elbow pain include botulinum toxin and hyaluronate propelling growth of the elbow lesion market. Platelet-rich plasma (PRP), a novel technique, is being preferred for treatment of tennis elbow. It involves taking a blood sample from the patient, which is then treated to increase the number of platelets compared with other cells in the sample. Physical therapies such as muscle stimulation and ice massage are used to expedite the healing process.

Request Sample Copy Of This Report: https://www.coherentmarketinsights.com/insight/request-sample/96

Increasing number of sports events and competitions in the U.S, increasing patient awareness, good medical facilities, and favorable reimbursement policies are factors fueling growth of the elbow lesion market. Elbow injuries are considered to be an expected consequence of throwing sports. According to a study published in Orthopaedic Journal of Sports Medicine in 2013, 30% of baseball players will have elbow pain every year, and nearly 60% of players with elbow pain will show radiographic abnormalities. The elbow lesion market in emerging markets such as India, China, Russia, and Brazil is growing due to increase in number of sports injuries in these regions, use of advanced technology in diagnosis, and improving medical facilities offered by government and private companies.

Rise in prevalence of elbow tendon, increasing incidence of elbow joint pain, and growth in healthcare investment are factors driving growth of the global market for elbow lesion. According to the National Institute for Health and Care Excellence (NICE) tennis elbow was prevalent in 1%-3% of UK population in 2012. It has been observed that people above 60 years are more afflicted with elbow pain. Therefore, rapidly growing geriatric population and increasing incidence of arm fracture due to accidents are expected to drive growth of the elbow lesion market in the near future.

Key manufacturers of elbow braces for athletes include Mueller Sports Medicine and Professional Orthopedic Products, among others.

For More Information On This Report, Please Visit @ https://www.coherentmarketinsights.com/ongoing-insight/elbow-lesion-market-96